Quintiles to More Heavily Directly Invest in the Drugs Which it Evaluates – But Not to Worry, Says an Expert?
Posted by medical student in health blog dated February 4th, 2012
The Associated Press just reported on the latest trend in commercially sponsored clinical research, direct investment by contract research organizations (CROs) in the development of specific drugs by particular pharmaceutical or biotechnology companies. Here is the background in the article:
Robert ‘Humphrey’ Havard – Medical ‘Inkling’
Posted by medical student in blogging dated January 29th, 2012
Charlton, BG. Reflections on a scientific paper of 1926 by the medical ‘Inkling’ Robert Emlyn ‘Humphrey’ Havard (1901–1985). Medical Hypotheses. 2009; Volume 72: Pages 619-620
Don’t Be Afraid; Very Old Patients Treated With Vitamin K Antagonists, If Adequately Managed, Benefit From Anticoagulation
Posted by medical student in health blog dated November 25th, 2011
Results of the EPICA Study (Elderly Patients followed by Italian Centres for Anticoagulation Study), were presented at the ESC Congress 2011. This is the largest study on very old patients anticoagulated with Vitamin K antagonists for the prevention of venous thromboembolism and, for the major part (75%), for the prevention of stroke because affected by [...]
